The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

Analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued on Sunday. The firm set a “sell” rating on the stock. Ampio ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

If you're too busy to keep monitoring your stock portfolio every other day ... Beyond that, the pharmaceutical company has a robust pipeline. Its weight loss candidates, including retatrutide ...

Mirum Pharmaceuticals, Inc. (MIRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where Centessa Pharmaceuticals plc (NASDAQ:CNTA) stands against the ...